NCT05884346 Association Between Coronary and Peripheral Vascular Injury in Heart Failure Patients With Preserved Ejection Fraction. Status UNKNOWN Phase NA
NCT05878912 The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction Status RECRUITING Phase NA
NCT05873634 HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets Status RECRUITING Phase N/A
NCT05839730 Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction Status RECRUITING Phase NA
NCT05839028 Mechanisms of LV Remodeling in Hypertensive Patients Working on a Rotational Expeditionary Basis in the Arctic Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05838287 Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants Status RECRUITING Phase PHASE4
NCT05828888 CHIP in Endothelial Dysfunction Associated With HEpEF Status NOT_YET_RECRUITING Phase N/A
NCT05826821 Biomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular Disease Status COMPLETED Phase N/A
NCT05824923 A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure Status RECRUITING Phase PHASE3
NCT05822622 Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease. Status UNKNOWN Phase N/A
NCT05795400 Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy Status COMPLETED Phase NA
NCT05753553 Incidence and Echocardiographic Predictors of HFpEF in High-Risk Population Afferent to Italian Echo-labs Network Status UNKNOWN Phase N/A
NCT05723679 Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF Status RECRUITING Phase NA
NCT05719714 Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease Status RECRUITING Phase PHASE1/PHASE2
NCT05715697 Renal Denervation in Patients With Chronic Heart Failure With Preserved Ejection Fraction Status RECRUITING Phase NA